Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Aug 15;216(4):405-414.
doi: 10.1093/infdis/jix282.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

Affiliations
Observational Study

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

Melissa K Andrew et al. J Infect Dis. .

Abstract

Background: Influenza is an important cause of morbidity and mortality among older adults. Even so, effectiveness of influenza vaccine for older adults has been reported to be lower than for younger adults, and the impact of frailty on vaccine effectiveness (VE) and outcomes is uncertain. We aimed to study VE against influenza hospitalization in older adults, focusing on the impact of frailty.

Methods: We report VE of trivalent influenza vaccine (TIV) in people ≥65 years of age hospitalized during the 2011-2012 influenza season using a multicenter, prospective, test-negative case-control design. A validated frailty index (FI) was used to measure frailty.

Results: Three hundred twenty cases and 564 controls (mean age, 80.6 and 78.7 years, respectively) were enrolled. Cases had higher baseline frailty than controls (P = .006). In the fully adjusted model, VE against influenza hospitalization was 58.0% (95% confidence interval [CI], 34.2%-73.2%). The contribution of frailty was important; adjusting for frailty alone yielded a VE estimate of 58.7% (95% CI, 36.2%-73.2%). VE was 77.6% among nonfrail older adults and declined as frailty increased.

Conclusions: Despite commonly held views that VE is poor in older adults, we found that TIV provided good protection against influenza hospitalization in older adults who were not frail, though VE diminished as frailty increased.

Clinical trials registration: NCT01517191.

Keywords: elderly; frailty; hospitalization; influenza; vaccine effectiveness.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Patient disposition. Abbreviations: N, number of subjects in group; n, number of subjects fulfilling case definition; VE, vaccine effectiveness.
Figure 2.
Figure 2.
Laboratory-confirmed influenza cases and test-negative controls by week and virus subtype, 1 November 2011 to 25 May 2012. Includes all laboratory-confirmed cases enrolled by the Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network over the study period. Of the 588 cases enrolled, 528 cases were included in the vaccine effectiveness analysis.

Comment in

References

    1. Castilla J, Guevara M, Martínez-Baz I et al. . Enhanced estimates of the influenza vaccination effect in preventing mortality: a prospective cohort study. Medicine (Baltimore) 2015; 94:e1240. - PMC - PubMed
    1. Chan TC, Fan-Ngai Hung I, Ka-Hay Luk J, Chu LW, Hon-Wai Chan F. Effectiveness of influenza vaccination in institutionalized older adults: a systematic review. J Am Med Dir Assoc 2014; 15:226 e1–6. - PubMed
    1. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373–81. - PubMed
    1. Rivetti D, Jefferson T, Thomas R et al. . Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006; CD004876. doi:10.1002/14651858.CD004876.pub2. - PubMed
    1. Darvishian M, Bijlsma MJ, Hak E, van den Heuvel ER. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis 2015; 14:1228–39. - PubMed

Publication types

Substances

Associated data

Grants and funding